Christopher Francis, Ph.D., serves as the Senior Vice President of Corporate Development and Head of Emerging Areas at WAVE Life Sciences Ltd., a biotechnology company focused on developing innovative treatments for serious diseases. Dr. Francis brings a wealth of experience and expertise to his role, having spent over two decades in the life sciences industry. He holds a Ph.D. in Biochemistry from the University of Cambridge and has a strong track record of driving strategic initiatives and fostering collaborations that have propelled the growth and success of various organizations. Prior to joining WAVE Life Sciences, Dr. Francis held leadership positions at several prominent biotechnology companies, including Alnylam Pharmaceuticals and Biogen. At Alnylam, he played a key role in the company's strategic partnerships and business development efforts, contributing to the advancement of RNAi therapeutics. During his tenure at Biogen, Dr. Francis was instrumental in the development and commercialization of multiple sclerosis therapies, demonstrating his ability to navigate complex scientific and business landscapes. In his current role at WAVE Life Sciences, Dr. Francis is responsible for overseeing the company's corporate development strategy, including identifying and executing strategic partnerships, licensing agreements, and acquisitions that align with the company's mission. Additionally, as Head of Emerging Areas, he leads the exploration and development of new therapeutic platforms and technologies that have the potential to transform the treatment landscape for patients with serious diseases. Dr. Francis's leadership and vision have been instrumental in positioning WAVE Life Sciences as a frontrunner in the development of novel RNA-based therapies, and his contributions continue to drive the company's growth and success.